|
PSMG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.783200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.949000E-01 |
| Normal-vs-Stage2 |
2.556800E-01 |
| Normal-vs-Stage3 |
7.706800E-01 |
| Normal-vs-Stage4 |
6.074000E-01 |
| Stage1-vs-Stage2 |
6.760200E-01 |
| Stage1-vs-Stage3 |
2.699000E-01 |
| Stage1-vs-Stage4 |
8.425400E-01 |
| Stage2-vs-Stage3 |
2.847200E-01 |
| Stage2-vs-Stage4 |
9.998600E-01 |
| Stage3-vs-Stage4 |
4.699200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.628200E-01 |
| Normal-vs-AfricanAmerican |
1.940180E-01 |
| Normal-vs-Asian |
4.358600E-01 |
| Caucasian-vs-AfricanAmerican |
3.180800E-01 |
| Caucasian-vs-Asian |
6.901400E-01 |
| AfricanAmerican-vs-Asian |
9.599600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.380400E-01 |
| Normal-vs-Female |
1.972240E-01 |
| Male-vs-Female |
3.276800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.401500E-02 |
| Normal-vs-Extreme_Weight |
6.419600E-01 |
| Normal-vs-Obese |
9.974400E-01 |
| Normal-vs-Extreme_Obese |
7.153600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.245030E-01 |
| Normal_Weight-vs-Obese |
7.504400E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.930200E-01 |
| Extreme_Weight-vs-Obese |
6.357200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.269000E-01 |
| Obese-vs-Extreme_Obese |
7.507800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.034000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.691810E-01 |
| Normal-vs-Age(61-80Yrs) |
5.784800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.230400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.508000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.143200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.003000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.976000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.037400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.853200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.193000E-01 |
| Normal-VS-Type2 PRCC |
8.958200E-01 |
| Normal-VS-KIRP CIMP |
3.838000E-01 |
| Normal-VS-Unclassified PRCC |
9.172200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.995200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.914570E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.512800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.105000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.417200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.307600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.319400E-01 |
| Normal-vs-N1 |
3.752200E-01 |
| Normal-vs-N2 |
1.570390E-01 |
| N0-vs-N1 |
5.401200E-01 |
| N0-vs-N2 |
2.147800E-01 |
| N1-vs-N2 |
2.323600E-01 |
|
|
